TYR and melanoma: It was revealed that TYR inhibitors could sensitize melanoma cells to the cytotoxic effects of cyclophosphamide and could enhance the activity of IL-2, reducing the effective cell proliferation inhibitory concentration from the original 10−3 M to 10−6 M [31].